Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months

The late investing legend Charlie Munger talked about a "fat-pitch strategy," a baseball analogy about waiting for a big, no-brainer opportunity you can take advantage of. When you get that fat pitch, it's a chance to get a home run. In investing, it means potentially securing a massive return.And that's what comes to mind when I think about the recent sell-off in Viking Therapeutics (NASDAQ: VKTX). Investors unloaded the stock after some disappointing clinical trial data. It looked like an incredible overreaction in the markets: The stock plummeted more than 40% in a single day. With a sell-off like that, you might assume that the company was on the verge of bankruptcy or experiencing a massive scandal that could jeopardize its future.None of that happened. So if you're a long-term investor who's willing to take on some risk, Viking Therapeutics is a pharma stock you should consider buying right now. I predict that within the next 12 months, it'll double in value.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool